Zimmer Biomet Holdings Inc
Cerrado
SectorSanidad
89.97 2.76
Resumen
Variación precio
24h
Mínimo
87.54
Máximo
90.5
Ingresos | 99M 239M |
|---|---|
Ventas | -157M 2.1B |
P/B Media del Sector | 22.797 50.958 |
BPA | 2.09 |
Rentabilidad por dividendo | 1.1 |
Margen de beneficios | 11.43 |
Empleados | 17,000 |
EBITDA | 84M 538M |
Recomendaciones | Neutral |
|---|---|
Estimación a 12 Meses | +7.02% upside |
Rentabilidad por dividendo Media del Sector | 1.10% 2.41% |
|---|---|
Próximas Ganancias | 6 ago 2026 |
Fecha Próximo Dividendo | 31 jul 2026 |
Próxima Fecha de Ex Dividendo | 25 jun 2026 |
Capitalización Mercado | -899M 17B |
|---|---|
Apertura anterior | 87.21 |
Cierre anterior | 89.97 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
146 / 342 Clasificación en Healthcare
Zimmer Biomet Holdings Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.